LM N°1/ 2024. GOOD PRACTICES FOR THE PREPARATION OF AUTOLOGOUS PLATELET-RICH PLASMA (PRP-A) FROM THE RECIPIENT'S OWN BLOOD. Daphné V. DIERMAN, PhD Pharmacist, Antoine TURZI, CEO RegenLab.
LM N°1/ 2024. MOTIVATION TO STUDY THE EFFECT OF PLATELET-RICH PLASMA (PRP) ON POST-CHEMOTHERAPY ALOPECIA (APC) AND POST-ENDOCRINE THERAPY ALOPECIA (APE). Leore LAVIN MS, Alex PAN MD, Anthony ROSSI MD, Antoine TURZI.
LM N°1/ 2024. EFFECTIVE HAIR RESTORATION IN PATIENTS WITH BALDNESS USING A BIO-REVITALIZATION TREATMENT. A PRELIMINARY PROSPECTIVE MEDICAL STUDY. Pilar REYES, MD, Gustavo H. LEIBASCHOFF, MD.
Topics still taboo
LM N°1/ 2024. EFFECTIVE HAIR RESTORATION IN PATIENTS WITH BALDNESS USING A BIO-REVITALIZATION TREATMENT. A PRELIMINARY PROSPECTIVE MEDICAL STUDY. Pilar REYES, MD, Gustavo H. LEIBASCHOFF, MD.
LM N°1/ 2024. CORRECTION OF AGE-RELATED CHANGES WITH AUTOLOGOUS THROMBIN-ACTIVATED PRP AND HYALURONIC ACID IN COMBINATION WITH RF-MICRONEEDLING EQUIPMENT. Inna SHARYPOVA, MD, PhD. Andrey ALENICHEV, MD, PhD.
LM N°1/ 2024. PLATELET-RICH PLASMA AS A SAFE AND EFFECTIVE AUTOLOGOUS TREATMENT FOR CHRONIC WOUND HEALING. Solange VISCHER, Antoine TURZI.
LM N°1/ 2024. PLATELET-RICH PLASMA AND CALCANEAL TENDINOPATHY. Marine DELCROS,MD.
LM N°1/ 2024. PLATELET-RICH PLASMA AS A TREATMENT FOR OSTEOARTHRITIS OF THE KNEE. Solange Vischer, Antoine Turzi.
LM N°1/ 2024. PLATELET-RICH PLASMA AND SYMPTOMATIC GONARTHROSIS. SUMMARY OF INTERNATIONAL RECOMMENDATIONS. M.Delcros
LM N°1/ 2024. THE CELLULAR MATRIX® REVOLUTION IN THE TREATMENT OF GONARTHROSIS: FROM AH VISCOSUPPLEMENTATION TO COMBINATION WITH PRP. Philippe ADAM MD, Marine DELCROS, MD - RegenLab
LM N°1/ 2024. OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES. Andreas PIGNI. Legal Affairs, RegenLab SA.
LM N°1/ 2024. PLATELET-RICH PLASMA (PRP) AS AN ALTERNATIVE TO FETAL CALF SERUM (FBS) IN THE EXPANSION OF HUMAN MYOBLASTS: AN IN VITRO PROTOCOL. Axel TOLLANCE, Diego MICHEL, Alexandre PROLA, Axelle BOUCHE, Antoine TURZI, Didier HANNOUCHE, Thomas LAUMONIER and Sarah BERNDT
No More Posts